Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.
about
Identification of a family of sorting nexin molecules and characterization of their association with receptorsStructural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7Identification of Nck family genes, chromosomal localization, expression, and signaling specificityThe tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gammaCharacterization of KIF1C, a new kinesin-like protein involved in vesicle transport from the Golgi apparatus to the endoplasmic reticulumTyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulationThe human GRB2 and Drosophila Drk genes can functionally replace the Caenorhabditis elegans cell signaling gene sem-5.The kinesin KIF1C and microtubule plus ends regulate podosome dynamics in macrophages.Cloning and expression of a widely expressed receptor tyrosine phosphataseEGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinibStructural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase diseaseErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylationIdentification of the human pim-1 gene product as a 33-kilodalton cytoplasmic protein with tyrosine kinase activityThe EGF receptor is an actin-binding proteinDistinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializationsInduction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase betaCHL1 is a nuclear protein with an essential ATP binding site that exhibits a size-dependent effect on chromosome segregation.Yeast Rio1p is the founding member of a novel subfamily of protein serine kinases involved in the control of cell cycle progression.Cloning and characterization of GRB14, a novel member of the GRB7 gene familyMig-6 is a negative regulator of the epidermal growth factor receptor signalConversion of a phosphoseryl/threonyl phosphatase into a phosphotyrosyl phosphataseRole of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptorTyrosine kinase activity is essential for the association of phospholipase C-gamma with the epidermal growth factor receptorc-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptorIdentification of the Drosophila melanogaster homologue of the mammalian signal transducer protein, Vav.Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.ATP and SH3 binding sites in the protein kinase of the large subunit of herpes simplex virus type 2 of ribonucleotide reductase (ICP10).Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells.Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II.High resolution structure of the HDGF PWWP domain: a potential DNA binding domain.Interferons block protein kinase C-dependent but not-independent activation of Raf-1 and mitogen-activated protein kinases and mitogenesis in NIH 3T3 cells.A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells.Direct selection of EGF mutants displayed on filamentous phage using cells overexpressing EGF receptor.Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptorsIntermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae.Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.Properties of the insulin receptor ectodomainLigand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regionsThe epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation
P2860
Q22008017-FB21F25F-20FA-44AA-AAAD-2987FB61EFFFQ24310358-FA3C3A1C-66AD-4A69-BE56-BEFBF98F4D78Q24313473-06C83C8A-3961-4F35-BF33-4B054386C5E8Q24314441-03111590-7062-42E3-BAB5-BE0D5B3E0EA5Q24318835-AC3E2FFB-8F8D-4009-83A9-9C842AB4F33AQ24336399-105EB627-3B9B-4DC2-BA41-B83FF02B2CD4Q24337241-DEF4B523-A19E-4F73-B857-A86C827972E2Q24547329-F10B3BB2-0EFE-48C9-B708-4B67D5C6258CQ24557510-79EF90E1-BE26-40CD-905E-29ED97D9EAA8Q24561953-E1C7656F-100A-4D22-ABD7-833A955AB3D9Q24564000-1328849D-DC33-4DE6-95DF-0B95B730D764Q24621754-36CDCFAE-5BC9-42F1-A82B-DE01FC13FF4DQ24632239-B8E59E0D-0C2F-4AE2-9547-A2BBE8597139Q24642959-4DE7A745-2EF6-4175-B09A-739BBFA1270CQ24680337-7185CC2F-7377-4A47-B7AD-0BFA470FC5DEQ24683911-04567679-18C2-4A8E-8BF5-306E82817DA6Q27932199-9EB15075-1849-484F-BA81-684A8C0B354DQ27932332-243E069F-726E-405E-8464-CC39FB230DE3Q28115522-A7EE20D3-CFE9-48E2-A9B5-3D41B04D16CFQ28201153-5D73FF43-8CDC-4A1B-8789-B842897E7E94Q28359919-955BD049-6D81-4605-8444-D9D114AF2004Q28359936-B4EAF5D8-7F09-4AA3-A6B7-8F6761D88706Q28609951-07B3BDEA-7160-4DE8-B462-F162C6AF251BQ29618661-4EF32DF8-B3F6-4C05-BD47-DF23C493EA41Q30175142-5B43A683-470F-438A-B12B-953F06A95F42Q30176591-EB641CCB-6CE7-4A23-850E-619C78931036Q30176888-1028574A-F100-4D07-B2C7-3D079DB7EFA3Q30307673-AD40EFF4-6354-4C28-B12D-783902BC8FB9Q30434083-66BC70F4-492C-4DC0-A25C-4E960571A353Q30439092-750753F4-3AB8-4C8F-BBF7-BD6B94F133F2Q30450194-7D3B9E4B-B550-4F37-A3C6-331DC2947C07Q30655101-3644FF7B-DEE1-4168-8DA8-ADE8F857E5D2Q30707023-95707252-918D-4E77-A7BF-075337780134Q31169174-502B1FE6-3023-4C31-9D1B-2BE5BE1082F3Q33584471-A7CDA553-5158-438F-9938-605978C2EEB4Q33639146-B7083565-612A-45A6-8E3A-B44CF0DEA2F2Q33654340-64DBA836-FBF0-43C3-8A8E-23CAE335552AQ33685781-A523CB96-CBBF-49FE-9487-470E5E8FF3FFQ33734567-51ED816B-E0A9-4169-8F63-B19642D88F96Q33834940-CB8912E4-0F02-45FA-A1F4-6B05F98AD542
P2860
Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Point mutation at the ATP bind ...... y and alters cellular routing.
@en
Point mutation at the ATP bind ...... y and alters cellular routing.
@nl
type
label
Point mutation at the ATP bind ...... y and alters cellular routing.
@en
Point mutation at the ATP bind ...... y and alters cellular routing.
@nl
prefLabel
Point mutation at the ATP bind ...... y and alters cellular routing.
@en
Point mutation at the ATP bind ...... y and alters cellular routing.
@nl
P2093
P1433
P1476
Point mutation at the ATP bind ...... y and alters cellular routing.
@en
P2093
Schlessinger J
Van Obberghen E
P304
P356
10.1016/0092-8674(87)90147-4
P407
P577
1987-10-01T00:00:00Z